US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist

0.4854
-0.0267-5.21%

Close Jul 3 13:00 ET

0.5000
+0.0146+3.01%

Pre 08:00 ET

87.70MMarket Cap-2110P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

(Q3)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

-16.95%-28.36M

-13.26%-6.33M

-59.88%-7.71M

Net income from continuing operations

18.83%-8.54M

-156.88%-9.23M

3.26%-32.54M

-24.44%-9.94M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

-45.92%-33.64M

-61.07%-7.99M

-52.19%-8.86M

Depreciation and amortization

8.16%52.07K

8.10%51.01K

8.15%194.32K

8.04%49.97K

8.09%49.02K

8.26%48.14K

8.20%47.19K

8.98%179.68K

8.14%46.25K

8.79%45.35K

Deferred tax

0.00%144K

0.00%576K

-75.00%144K

--144K

--576K

--0

Other non cash items

--98.08K

--76.15K

-73.03%102K

--0

----

456.18%378.2K

--104.32K

--0

Change In working capital

-315.48%-2.61M

91.10%-233.46K

-1,772.40%-4.01M

-180.37%-126.19K

-2,508.46%-2.47M

136.24%1.21M

-174.32%-2.62M

108.82%239.56K

95.35%-45.01K

-82.47%102.57K

-Change in prepaid assets

-183.52%-1.15M

100.97%25.01K

-4,430.59%-5.04M

8.15%-57.19K

-595.21%-2M

-2,083.45%-405.48K

-1,283.16%-2.58M

95.72%-111.18K

95.76%-62.26K

-5,197.80%-287.21K

-Change in payables and accrued expense

-115.69%-377.13K

-10,541.30%-205.8K

23.99%832.86K

-35.15%-568.91K

-1,906.25%-1M

227.58%2.4M

-99.93%1.97K

421.06%671.72K

-336.95%-420.95K

-119.86%-50.04K

-Change in other current liabilities

-10.93%-53.74K

-10.92%-52.68K

-11.14%-196.99K

-10.93%-51.64K

-11.22%-49.42K

-11.22%-48.44K

-11.22%-47.49K

-11.47%-177.24K

-11.22%-46.55K

-11.56%-44.43K

-Change in other working capital

----

374.60%394.73K

13.78%551.54K

19.70%579.67K

----

-157.25%-143.75K

32.38%484.75K

31.79%484.25K

Cash from discontinued investing activities

Operating cash flow

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

-16.95%-28.36M

-13.26%-6.33M

-59.88%-7.71M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

13.83M

-687

Net common stock issuance

----

--13.8M

---31.95K

----

--0

----

Proceeds from stock option exercised by employees

----

--31.27K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

----

--13.83M

---687

--13.8M

----

--0

Net cash flow

Beginning cash position

-44.84%20.35M

-36.51%26.48M

-40.47%41.71M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

-40.47%41.71M

405.59%70.07M

-58.46%48.04M

-46.23%55.76M

Current changes in cash

0.46%-7.79M

-27.17%-6.14M

46.30%-15.23M

-7.40%-6.8M

154.67%4.22M

19.07%-7.82M

-3.72%-4.82M

-150.45%-28.36M

86.11%-6.33M

-164.45%-7.71M

End cash Position

-56.79%12.56M

-44.84%20.35M

-36.51%26.48M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

-40.47%41.71M

-58.46%48.04M

Free cash flow

0.85%-7.79M

-27.17%-6.14M

-2.46%-29.06M

-7.39%-6.8M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

55.86%-28.36M

86.11%-6.33M

-59.65%-7.71M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022	(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M	-16.95%-28.36M	-13.26%-6.33M	-59.88%-7.71M
Net income from continuing operations	18.83%-8.54M	-156.88%-9.23M	3.26%-32.54M	-24.44%-9.94M	4.34%-8.48M	-39.21%-10.53M	61.05%-3.59M	-45.92%-33.64M	-61.07%-7.99M	-52.19%-8.86M
Depreciation and amortization	8.16%52.07K	8.10%51.01K	8.15%194.32K	8.04%49.97K	8.09%49.02K	8.26%48.14K	8.20%47.19K	8.98%179.68K	8.14%46.25K	8.79%45.35K
Deferred tax	0.00%144K	0.00%144K	0.00%576K	-75.00%144K	--144K	--144K	--144K	--576K	--576K	--0
Other non cash items	--98.08K	--76.15K	-73.03%102K	--0	--0	----	----	456.18%378.2K	--104.32K	--0
Change In working capital	-315.48%-2.61M	91.10%-233.46K	-1,772.40%-4.01M	-180.37%-126.19K	-2,508.46%-2.47M	136.24%1.21M	-174.32%-2.62M	108.82%239.56K	95.35%-45.01K	-82.47%102.57K
-Change in prepaid assets	-183.52%-1.15M	100.97%25.01K	-4,430.59%-5.04M	8.15%-57.19K	-595.21%-2M	-2,083.45%-405.48K	-1,283.16%-2.58M	95.72%-111.18K	95.76%-62.26K	-5,197.80%-287.21K
-Change in payables and accrued expense	-115.69%-377.13K	-10,541.30%-205.8K	23.99%832.86K	-35.15%-568.91K	-1,906.25%-1M	227.58%2.4M	-99.93%1.97K	421.06%671.72K	-336.95%-420.95K	-119.86%-50.04K
-Change in other current liabilities	-10.93%-53.74K	-10.92%-52.68K	-11.14%-196.99K	-10.93%-51.64K	-11.22%-49.42K	-11.22%-48.44K	-11.22%-47.49K	-11.47%-177.24K	-11.22%-46.55K	-11.56%-44.43K
-Change in other working capital	----	----	374.60%394.73K	13.78%551.54K	19.70%579.67K	----	----	-157.25%-143.75K	32.38%484.75K	31.79%484.25K
Cash from discontinued investing activities
Operating cash flow	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M	-16.95%-28.36M	-13.26%-6.33M	-59.88%-7.71M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities			13.83M	-687				0	0	0
Net common stock issuance	----	----	--13.8M	---31.95K	----	----	----	--0	--0	----
Proceeds from stock option exercised by employees	----	----	--31.27K	----	----	----	----	--0	----	----
Cash from discontinued financing activities
Financing cash flow	----	----	--13.83M	---687	--13.8M	----	----	--0	--0	--0
Net cash flow
Beginning cash position	-44.84%20.35M	-36.51%26.48M	-40.47%41.71M	-30.73%33.28M	-47.87%29.07M	-43.62%36.89M	-40.47%41.71M	405.59%70.07M	-58.46%48.04M	-46.23%55.76M
Current changes in cash	0.46%-7.79M	-27.17%-6.14M	46.30%-15.23M	-7.40%-6.8M	154.67%4.22M	19.07%-7.82M	-3.72%-4.82M	-150.45%-28.36M	86.11%-6.33M	-164.45%-7.71M
End cash Position	-56.79%12.56M	-44.84%20.35M	-36.51%26.48M	-36.51%26.48M	-30.73%33.28M	-47.87%29.07M	-43.62%36.89M	-40.47%41.71M	-40.47%41.71M	-58.46%48.04M
Free cash flow	0.85%-7.79M	-27.17%-6.14M	-2.46%-29.06M	-7.39%-6.8M	-24.25%-9.58M	18.75%-7.85M	-3.72%-4.82M	55.86%-28.36M	86.11%-6.33M	-59.65%-7.71M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall